Feasibility of Minimally Invasive Lymphadenectomy in Bladder and Prostate Cancer Surgery

Urologic Clinics of North America

Volumn 38, Issue 4, 2011, Pages 407-418

  Hakimi, A Ari ^a   Ghavamian, Reza ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; Lymphadenectomy; Prostate cancer; Robotic cystectomy; Robotic prostatectomy

Indexed keywords

BLADDER CANCER; CANCER SURGERY; CYSTECTOMY; FEASIBILITY STUDY; HIGH RISK POPULATION; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; ROBOTICS; SURGICAL APPROACH;

CYSTECTOMY; FEASIBILITY STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; ROBOTICS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 80955159743     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2011.07.003     Document Type: Review

References (47)

1. Cheng L., Zincke H., Blute M.L., et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001, 91:66-73.
2. Allaf M.E., Palapattu G.S., Trock B.J., et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004, 172:1840-1844.
3. Masterson T.A., Bianco F.J., Vickers A.J., et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006, 175:1320-1324.
4. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997, 277(18):1445-1451.
5. Kattan M.W., Eastham J.A., Stapleton A.M., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998, 90(10):766-771.
6. Wagner M., Sokoloff M., Daneshmand S. The role of pelvic lymphadenectomy for prostate cancer-therapeutic?. J Urol 2008, 179(2):408-413.
7. Kawakami J., Meng M.V., Sadetsky N., et al. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol 2006, 176(4 Pt 1):1382-1386. CaPSURE Investigators.
8. Prasad S.M., Keating N.L., Wang Q., et al. Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. Urology 2008, 72(3):647-652.
9. Feifer A.H., Elkin E.B., Lowrance W.T., et al. Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 2011, [Epub ahead of print].
10. Heidenreich A., Varga Z., Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002, 167:1681-1686.
11. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006, 49:1019-1026.
12. Schumacher M.C., Burkhard F.C., Thalmann G.N., et al. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 2008, 54(2):344-352.
13. Rassweiler J., Seemann O., Schulze M., et al. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 2003, 169(5):1689-1693.
14. Tooher R., Swindle P., Woo H., et al. Laparoscopic radical prostatectomy for localized prostate cancer: a systematic review of comparative studies. J Urol 2006, 175(6):2011-2017.
15. Ficarra V., Novara G., Artibani W., et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009, 55(5):1037-1063.
16. Eden C.G., Arora A., Rouse P. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer. BJU Int 2010, 106(4):537-542.
17. Wyler S.F., Sulser T., Seifert H.H., et al. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer. Urology 2006, 68(4):883-887.
18. Lattouf J.B., Beri A., Jeschke S., et al. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results. Eur Urol 2007, 52(5):1347-1355.
19. Zorn K.C., Katz M.H., Bernstein A., et al. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications. Urology 2009, 74(2):296-302.
20. Yee D.S., Katz D.J., Godoy G., et al. Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience. Urology 2010, 75(5):1199-1204.
21. Feicke A., Baumgartner M., Talimi S., et al. Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol 2009, 55(4):876-883.
22. Ng C.K., Kauffman E.C., Lee M.M., et al. A comparison of postoperative complications in open versus robotic cystectomy. Eur Urol 2010, 57(2):274-281.
23. Sánchez de Badajoz E., Gallego Perales J.L., Reche Rosado A., et al. Radical cystectomy and laparoscopic ileal conduit. Arch Esp Urol 1993, 46:621-624.
24. Hrouda D., Adeyoju A.A., Gill I.S. Laparoscopic radical cystectomy and urinary diversion: fad or future?. BJU Int 2004, 94:501-505.
25. Gupta N.P., Gill I.S., Fergany A., et al. Laparoscopic radical cystectomy with intracorporeal ileal conduit diversion: 5 cases with a 2-year follow-up. BJU Int 2002, 90:391-396.
26. Finelli A., Gill I.S., Desai M.M., et al. Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. J Urol 2004, 172:1809-1812.
27. Haber G.P., Gill I.S. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years. BJU Int 2007, 100:137-142.
28. Porpiglia F., Renard J., Billia M., et al. Open versus laparoscopy-assisted radical cystectomy: results of a prospective study. J Endourol 2007, 21:325-329.
29. Hemal A.K., Kolla S.B. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience. J Urol 2007, 178:2340-2343.
30. Menon M., Hemal A.K., Tewari A., et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int 2003, 92:232-236.
31. Wang G.J., Barocas D.A., Raman J.D., et al. Robotic vs. open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int 2008, 101:89-93.
32. Pruthi R.S., Wallen E.M. Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes. J Urol 2007, 178(3):814-818.
33. Guru K.A., Sternberg K., Wilding G.E., et al. The lymph node yield during robot-assisted radical cystectomy. BJU Int 2008, 102:231-234.
34. Pruthi R.S., Nielsen M.E., Nix J., et al. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol 2010, 183(2):510-514.
35. Nix J., Smith A., Kurpad R., et al. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol 2010, 57(2):196-201.
36. Hellenthal N.J., Hussain A., Andrews P.E., et al. Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU Int 2011, 107(4):642-646.
37. Leissner J., Ghoneim M.A., Abol-Enein H., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004, 171:139-144.
38. Stein J.P., Cai J., Groshen S., et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003, 170:35-41.
39. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002, 167:1295-1298.
40. Pruthi R.S., Wallen E.M. Robotic-assisted laparoscopic pelvic lymphadenectomy for bladder cancer: a surgical atlas. J Laparoendosc Adv Surg Tech A 2009, 19(1):71-74.
41. Lavery H.J., Martinez-Suarez H.J., Abaza R. Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield. BJU Int 2011, 107(11):1802-1805.
42. Skinner D.G. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982, 128:34-36.
43. Pruthi R.S., Smith A., Wallen E.M. Evaluating the learning curve for robot-assisted laparoscopic radical cystectomy. J Endourol 2008, 22:2469-2474.
44. Guru K.A., Perlmutter A.E., Butt Z.M., et al. The learning curve for robot-assisted radical cystectomy. JSLS 2009, 13:509-514.
45. Hayn M.H., Hellenthal N.J., Hussain A., et al. Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. Urology 2010, 76(5):1111-1116.
46. Wiesner C., Salzer A., Thomas C., et al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 2009, 104(3):331-335.
47. Davis J.W., Gaston K., Anderson R., et al. Robot assisted extended pelvic lymphadenectomy at radical cystectomy: lymph node yield compared with second look open dissection. J Urol 2011, 185(1):79-83.